Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure

Cardiology Journal

Volumn 16, Issue 6, 2009, Pages 493-499

  Korewicki, Jerzy ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Cardiac transplantation; Prognosis; Severe heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; INOTROPIC AGENT;

ASSISTIVE TECHNOLOGY DEVICE; CARDIAC GRAFT REJECTION; CARDIAC PATIENT; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; POLAND; PROGNOSIS; REGISTER; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; TREATMENT INDICATION;

ADULT; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; PATIENT SELECTION; POLAND; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 74249113209     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail, 2001; 3: 315-322.
2. Klotz S, Loeher A, Drees G, Scheld HH. Surgical therapy of end-stage heart failure. State of the art 2006. Herz, 2006; 31: 445-454.
3. Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr Opin Cardiol, 2008; 23: 249-253.
4. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS trial study group. N Engl J Med, 1987; 4: 1429-1435.
5. Domanski MJ, Krause-Steinrauf H, Massie BM et al. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail, 2003; 9: 354-363.
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med, 1991; 1: 293-302.
7. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation, 1994; 90: 1765-1773.
8. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med, 1996; 23: 1349-1355.
9. Cleland JGF, Louis A, Witte K. Pharmacoeconomics in heart failure: Impact of drug and non-drug based treatment. Eur Heart J, 2001; 3 (suppl. G): G25-G32.
10. Cleland JGF, Khand A, Clark AC. The heart failure epidemiology: Exactly how big is it? Eur Heart J, 2001; 22: 623-665.
11. Gardner R, Mc Donagh T, Mac D et al. Who needs a heart transplant? Eur Heart J, 2006; 27: 770-772.
12. Butler J, Khadim G, Paul KM et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol, 2004; 43: 787-793.
13. Taylor DO, Edwards LB, Boucek MM et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult heart transplant report - 2005. J Heart Lung Transplant, 2005; 24: 945-955.
14. Almenar-Bonet L. Spanish Working Groups on Heart Transplantation. Spanish heart transplantation registry. 18th official report of the Spanish Society of Cardiology working group on heart failure, heart transplantation and associated therapies (1984-2006). Rev Esp Cardiol, 2007; 60: 1177-1187.
15. Metra M, Ponikowski P, Dickstein K et al. Advanced chronic heart failure: a position statement from the Study Group on advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 2007; 9: 689-694.
16. Korewicki J, Browarek A, Zembala M et al. Ogólnopolski rejestr chorych z ciȩżka̧ niewydolnościa̧ serca, zakwalifikowanych do przeszczepu serca - POLKARD-HF 2003-2007. Folia Cardiologica Excerpta, 2008; 3: 403-421.
17. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol, 1983; 1: 831-836.
18. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation, 1997; 17: 2660-2667.
19. Koelling TM, Joseph S., Aaronson KD. Heart failure survival score continues to predict clinical outcome in patients with heart failure receiving beta-blockers. J Heart Lung Transplant, 2004; 23: 1414-1422.
20. Van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol, 1992; 1: 359-363.
21. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J, 2003; 24: 1735-1743.
22. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: Linear correlation with exercise tolerance. J Heart Lung Transplant, 2007; 26: 516-521.
23. Caderiraz M, Bayern MP, Deng MC. Cardiac transplantation: any role left? Heart Fail Clin, 2007; 3: 321-347.
24. Deng MC, Smith JM, Young JB. Proposition: The benefit of cardiac transplantation in stable outpatients with heart failure should be tested in a randomized trial. J Heart Lung Transplant, 2003; 22: 113-117.
25. Jimendez J, Edwards LB, Higgins R et al. Should stable UNOS status 2 patients be transplanted? J Heart Lung Transplant, 2005; 24: 178-183.
26. Lund LH, Aaronson KD, Mancini DM. Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol, 2003; 1: 1350-1354.